Prescribing during pregnancy

Robertson, Deborah

Abstract

Last month, the research roundup provided you with an overview of articles looking at adverse drug reactions (Robertson, 2023). This month, three articles will be reviewed that look at the complex issues encountered when prescribing during pregnancy will be reviewed. The first article looks at polypharmacy and associated risks, the second examines the use of antidepressants and the risk of gestational diabetes and the third looks at the impact of regulatory safety notices on prescribing valproate in women with childbearing potential.

Citation

Robertson, D. (2023). Prescribing during pregnancy. Journal of Prescribing Practice, 5(3), 100-101. https://doi.org/10.12968/jprp.2023.5.3.100

• Journal Article Type: Other
• Acceptance Date: Feb 21, 2023
• Publication Date: Mar 2, 2023
• Deposit Date: Dec 21, 2023
• Publicly Available Date: Jan 2, 2024
• Journal: Journal of Prescribing Practice
• Print ISSN: 2631-8385
• Electronic ISSN: 2631-8393
• Publisher: MA Healthcare
• Peer Reviewed: Not Peer Reviewed
• Volume: 5
• Issue: 3
• Pages: 100-101
• DOI: https://doi.org/10.12968/jprp.2023.5.3.100
• Keywords: Pharmacology (medical); Pharmacology (nursing)